Prof. Adrian Bloor is a renowned Consultant Haematologist at The Christie Private Care. He also holds an NHS post at The Christie NHS Trust, where he serves as the Lead Clinician for Lymphoproliferative Disorders and the Haematology Research Team. In 2019, he was awarded an Honorary Clinical Chair at the University of Manchester.

Prof. Bloor has extensive experience in managing haematological malignancies, including lymphoma, leukaemia, and myeloma. He has a special interest in lymphoid malignancies, such as chronic lymphocytic leukaemia (CLL) and lymphoma, as well as stem cell transplantation and clinical trials.

He qualified in Medicine from Cambridge University and completed his specialist training in Haematology at University College London Hospital. He holds Fellowships with the Royal College of Physicians and the Royal College of Pathologists and was awarded a PhD for his research into molecular haemopoiesis.

Prof. Bloor is the Principal or Chief Investigator for numerous trials in Haemato-Oncology and Stem Cell Transplantation. He is a member of several key committees and groups, including the NCRI CLL Clinical Trials Committee, the Blood and Stem Cell Transplantation Clinical Reference Group (NHS England), and the Leeds CLL Trials Management Group. Additionally, he is part of the UK CLL Forum Executive Committee and serves on Medical Advisory Panels for Lymphoma Action, Leukaemia Care, and Bloodwise.

Prof. Bloor has been dedicated to advancing the field of haematology since his appointment and continues to contribute significantly to both clinical practice and research.